Advy Biosciences supported the Department of Neonatology during FY 2025–2026 by providing an ultrasound machine for neonatal care.

The machine enables bedside cardiac, circulatory, cranial, and line-position assessments for critically ill newborns, supporting faster and safer diagnosis and treatment without shifting babies during emergencies. It assists in detecting conditions such as shock, pulmonary hypertension, PDA, brain bleeding, hydrocephalus, and brain injury, while also ensuring accurate placement of critical tubes and lines.

Approximately 100 ultrasounds are performed daily in the NICU across nearly 40 babies.